-
IntroducedMar 07, 2023
-
Passed AssemblyApr 25, 2023
-
Passed SenateMay 26, 2023
-
Signed into Law
Establishes provisions governing prescription drugs. (BDR 40-782)
Last Action See all actions
executive • Jun 06, 2023: (No further action taken.)
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on AB 250
Tweets
Whip Lists
Sponsors
- Natha Andersonprimary
Votes
YES: 27
- Anderson, Natha
- Backus, Shea
- Bilbray-Axelrod, Shannon
- Brown-May, Tracy
- Carter, Max
- Cohen, Lesley
- Considine, Venicia
- D'Silva, Reuben
- González, Cecelia
- Gorelow, Michelle
- Jauregui, Sandra
- La Rue Hatch, Selena
- Marzola, Elaine
- Miller, Brittney
- Miller, Cameron
- Monroe-Moreno, Daniele
- Mosca, Erica
- Newby, Sabra
- Nguyen, Duy
- Orentlicher, David
- Peters, Sarah
- Summers-Armstrong, Shondra
- Taylor, Angie
- Thomas, Clara
- Torres, Selena
- Watts, Howard
- Yeager, Steve
NO: 15
OTHER: 0
Actions
- Jun 06, 2023 | executive
- (No further action taken.)
- Jun 05, 2023 | executive
- Vetoed by the Governor.
- May 30, 2023 | executive
- Senate Amendment No. 644 concurred in. To enrollment. Enrolled and delivered to Governor.
- May 29, 2023 | Assembly
- In Assembly.
- May 26, 2023 | Senate
- Read third time. Passed, as amended. Title approved, as amended. Preamble adopted, as amended. (Yeas: 13, Nays: 7, Excused: 1.) To Assembly.
- May 25, 2023 | Senate
- Taken from General File. Placed on General File for next legislative day.
- May 24, 2023 | Senate
- From printer. To re-engrossment. Re-engrossed. Second reprint. Taken from General File. Placed on General File for next legislative day.
- May 23, 2023 | Senate
- From committee: Amend, and do pass as amended. Placed on Second Reading File. Read second time. Amended. (Amend. No. 644.) To printer.
- May 19, 2023 | Senate
- Amend, and do pass as amended -- Senate Commerce and Labor (Work Session) May 19, 2023 9:00 AM
- May 15, 2023 | Senate
- Heard, No Action -- Senate Commerce and Labor May 15, 2023 8:00 AM
- Apr 26, 2023 | Senate
- In Senate. Read first time. Referred to Committee on Commerce and Labor. To committee.
- Apr 25, 2023 | Assembly
- From printer. To engrossment. Engrossed. First reprint. Read third time. Passed, as amended. Title approved. Preamble adopted. (Yeas: 27, Nays: 15.) To Senate.
- Apr 24, 2023 | Assembly
- From committee: Amend, and do pass as amended. Placed on Second Reading File. Read second time. Amended. (Amend. No. 439.) To printer.
- Apr 14, 2023 | Assembly
- Amend, and do pass as amended -- Assembly Commerce and Labor (Work Session) Apr 14, 2023 See Agenda
- Apr 03, 2023 | Assembly
- Heard -- Assembly Commerce and Labor Apr 03, 2023 1:30 PM
- Mar 08, 2023 | Assembly
- From printer. To committee.
- Mar 07, 2023 | Assembly
- Read first time. Referred to Committee on Commerce and Labor. To printer.
Documents
- Fiscal Note: Department of Business and Industry (As Introduced)PDF
- Fiscal Note: Office of the Attorney General (As Introduced)PDF
- Fiscal Note: Department of Health and Human Services, Health Care Financing and Policy (As Introduced)PDF
- Agenda: Senate Commerce and Labor, 05/19/2023
- Minutes: Senate Commerce and Labor, 05/19/2023
- Video: Senate Commerce and Labor, 05/19/2023
- Exhibit AB250 (R1)_Work Session Document_Cesar Melgarejo_Committee Policy Analyst -- Senate Commerce and Labor, 05/19/2023
- Agenda: Senate Commerce and Labor, 05/15/2023
- Minutes: Senate Commerce and Labor, 05/15/2023
- Video: Senate Commerce and Labor, 05/15/2023
- Exhibit AB250_Elizabeth Yanez support letter -- Senate Commerce and Labor, 05/15/2023
- Exhibit AB250_Oppostion Letter_Alisa Reinhardt_Bayer -- Senate Commerce and Labor, 05/15/2023
- Exhibit AB250_Opposition Letter_Various groups -- Senate Commerce and Labor, 05/15/2023
- Exhibit AB250_Opposition Letter_PhRMA -- Senate Commerce and Labor, 05/15/2023
- Exhibit AB250_Opposition Letter_Kaylynn Bowman PharmD MS Med_Nevada Pharmacy Alliance -- Senate Commerce and Labor, 05/15/2023
- Exhibit AB250_Opposition Letter_Brian Warren_Biotechology Innovation Organization -- Senate Commerce and Labor, 05/15/2023
- Exhibit AB250_Letters in Opposition -- Senate Commerce and Labor, 05/15/2023
- Exhibit AB250_Conceptual Amendment_Assemblywoman Venicia Considine -- Senate Commerce and Labor, 05/15/2023
- Exhibit AB250_RX Drug Cost Stability Act_Assemblywoman Venicia Considine -- Senate Commerce and Labor, 05/15/2023
- Agenda: Assembly Commerce and Labor, 04/14/2023
- Minutes: Assembly Commerce and Labor, 04/14/2023
- Video: Assembly Commerce and Labor, 04/14/2023
- Exhibit AB250 Work Session Document -- Assembly Commerce and Labor, 04/14/2023
- Agenda: Assembly Commerce and Labor, 04/03/2023
- Minutes: Assembly Commerce and Labor, 04/03/2023
- Video: Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Second Proposed Amendment, submitted by Assemblywoman Considine -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Proposed Amendment, submitted by Assemblywoman Considine -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB 250 Letter of Support, submitted by S. Horner -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Letter of Support, submitted by M. Guerrero -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Support, submitted by D. Lide -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Support, submitted by J. Partida Corona, MD -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Support, submitted by M. Fitzgerald on behalf of New Day Nevada -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Support, submitted by K. Wulfkuhle, State External Affairs Manager, for United States of CARE -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Support, submitted by S. Gleich, Chief Executive Director, on behalf of Nevada Diabetes Assn. -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Letter of Support, submitted by C. McMullen, President, on behalf of the Senior Coalition of Washoe County -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Opposition, submitted by J. Lau, Vice President, Ferrari Reeder, on behalf of Biotechnology Innovation Organization (Bio) -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Opposition, submitted by R. Finseth, President, Carrara Nevada, on behalf of PhRMA -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Opposition, submitted by D. Thompson on behalf of Pharmaceutical Industry Labor-Management Assn. (PILMA) -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Opposition, submitted by A. Barber, MD, FACS, President, NV Oncology Society, and L. Pierce, MD, FASTRO, FASCO, Chair of the Board, Assn. for Clinical Oncology -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Letter of Opposition, submitted by P. Kelly, President & CEO, Nevada Hospital Assn. -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Opposition, submitted by J. Laub, President, Nevada Biotechnology & Health Science Consortium -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Opposition, submitted by L. Lindahl, Vice President, on behalf of Healthcare Distribution Alliance (HDA) -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Opposition, submitted by S. Desselle, RPh, PhD, FAPhA, President of Applied Pharmacy Solutions -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Letter in Opposition, submitted by R. Aryel, M.D., M.B.A. -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Opposition, submitted by R. Hamson, Exec. Director Region Teams, on behalf of Epilepsy Foundation Nevada -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Neutral, submitted by T. McCoy, JD, Exec. Director, State Govt. Affairs, Nevada Chronic Care Collaborative -- Assembly Commerce and Labor, 04/03/2023
- Exhibit AB250 Testimony in Neutral, submitted by D. Gattine, Sr. Policy Consultant, on behalf of the Nat'l Academny for State Health Policy (NASHP) -- Assembly Commerce and Labor, 04/03/2023